The role of insulin receptor substrate 2 in hypothalamic and β cell function

Journal of Clinical Investigation

Volumn 115, Issue 4, 2005, Pages 940-950

  Choudhury, Agharul I ^a   Heffron, Helen ^a   Smith, Mark A ^b   Al Qassab, Hind ^a   Xu, Allison W ^c   Selman, Colin ^a   Simmgen, Marcus ^a   Clements, Melanie ^a   Claret, Marc ^a   MacColl, Gavin ^a   Bedford, David C ^a   Hisadome, Kazunari ^b   Diakonov, Ivan ^a   Moosajee, Vazira ^d   Bell, Jimmy D ^d   Speakman, John R ^e   Batterham, Rachel L ^a   Barsh, Gregory S ^c   Ashford, Michael L J ^b   Withers, Dominic J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; LEPTIN; MELANOCORTIN; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY HEIGHT; CELL FUNCTION; CELL POPULATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEPOLARIZATION; DIABETES MELLITUS; ENERGY; FEMALE; GENE; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HYPERPHAGIA; HYPOTHALAMUS FUNCTION; IMPAIRED GLUCOSE TOLERANCE; IRS2 GENE; MALE; MOUSE; NERVE CELL; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 20144389727     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI24445     Document Type: Article

References (38)

1. DeFronzo, R.A. 1997. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5:177-268.
2. Kulkarni, R.N., et al. 1999. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 96:329-339.
3. Woods, S.C., Letter, E.G., McKay, L.D., and Porte, D., Jr. 1979. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature. 282:503-505.
4. Bruning, J.C., et al. 2000. Role of brain insulin receptor in control of body weight and reproduction. Science. 289:2122-2125.
5. Obici, S., Feng, Z., Karkanias, G., Baskin, D.G., and Rossetti, L. 2002. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 5:566-572.
6. Air, E.L., et al. 2002. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nat. Med. 8:179-183.
7. Withers, D.J. 2001. Insulin receptor substrate proteins and neuroendocrine function. Biochem. Soc. Trans. 29:525-529.
8. Tamemoto, H., et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:182-186.
9. Araki, E., et al. 1994. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 372:186-190.
10. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-904.
11. Burks, D.J., et al. 2000. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature. 407:377-382.
12. Suzuki, R., et al. 2004. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice. J. Biol. Chem. 279:25039-25049.
13. Lin, X., et al. 2004. Dysregulation of insulin receptor substrate 2 in β cells and brain causes obesity and diabetes. J. Clin. Invest. 114:908-916. doi:10.1172/JCI200422217.
14. Kubota, N., et al. 2004. Insulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus. J. Clin. Invest. 114:917-927. doi:10.1172/JCI200421484.
15. Brady, M.J. 2004. IRS2 cakes center stage in the development of type 2 diabetes. J. Clin. Invest. 114:886-888. doi:10.1172/JCI200423108.
16. Novak, A., Guo, C, Yang, W., Nagy, A., and Lobe, C.G. 2000. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis. 28:147-155.
17. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70-71.
18. Delacour, A., Nepote, V., Trumpp, A., and Herrera, P.L. 2004. Nestin expression in pancreatic exocrine cell lineages. Mech. Dev. 121:3-14.
19. Kubota, N., et al. 2000. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes. 49:1880-1889.
20. Dor, Y., Brown, J., Martinez, O.I., and Melton, D.A. 2004. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 429:41-46.
21. Cowley, M.A., et al. 2001. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 411:480-484.
22. Withers, D.J., et al. 1999. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat. Genet. 23:32-40.
23. Balthasar, N., et al. 2004. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron. 42:983-991.
24. Leibiger, I.B., Leibiger, B., Moede, T., and Berggren, P.O. 1998. Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol. Cell. 1:933-938.
25. Kulkarni, R.N., et al. 1999. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J. Clin. Invest. 104:R69-R75.
26. Zulewski, H., et al. 2001. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes. 50:521-533.
27. Lumelsky, N., et al. 2001. Differentiation of embryonic seem cells to insulin-secreting structures similar to pancreatic islets. Science. 292:1389-1394.
28. Treutelaar, M.K., et al. 2003. Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes. 52:2503-2512.
29. Tobe, K., et al. 2001. Increased expression of the sterol regulatory element-binding protein-1 gene in insulin receptor substrate-2(-/-) mouse liver. J. Biol. Chem. 276:38337-38340.
30. Marsh, D.J., et al. 1999. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat. Genet. 21:119-122.
31. Kaelin, C.B., Xu, A.W., Lu, X.Y., and Barsh, G.S. 2004. Transcriptional regulation of agouti-related protein (Agrp) in transgenic mice. Endocrinology. 145:5798-5806.
32. Roseberry, A.G., Liu, H., Jackson, A.C., Cai, X., and Friedman, J.M. 2004. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron. 41:711-722.
33. Postic, C., et al. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274:305-315.
34. Tronche, F., et al. 1999. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23:99-103.
35. Xu, A.W., et al. 2005. PI3K integrates the action of insulin and leptin on hypothalamic neurons. J. Clin. Invest. 115:951-958. doi:10.1172/JCI200524301.
36. Livak, K.J., and Schmittgen, T.D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402-408.
37. Ross, R., Leger, L., Guardo, R., De Guise, J., and Pike, B.C. 1991. Adipose tissue volume measured by magnetic resonance imaging and computerized tomography in rats. J. Appl. Physiol. 70:2164-2172.
38. Tang, H., Vasselli, J.R., Wu, E.X., Boozer, C.N., and Gallagher, D. 2002. High-resolution magnetic resonance imaging tracks changes in organ and tissue mass in obese and aging rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282:R890-R899.